Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + Rituximab in Indolent Non-Follicular NHL
NCT01830478Phase 2Unknown
- Sponsor
- Gruppo Italiano Studio Linfomi
- Start
- Apr 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in non-Hodgkin lymphoma (NHL), sponsored by Gruppo Italiano Studio Linfomi. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01830478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830478.